OnCore Login

Sponsor-Investigators

Nelson Yee

BTCRC-GI15-067

A phase II study to evaluate the efficacy of liposomal irinotecan in combination with oxaliplatin, leucovorin, and 5-fluorouracil for patients with locally advanced pancreatic carcinoma: Big Ten Cancer Research Consortium BTCRC-GI15-067
Status
Open to Accrual
Cancer Types
Pancreatic
Locations
Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Penn State Cancer Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Rutgers Cancer Institute of New Jersey
Read more
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278